Addex Therapeutics Ltd American Depositary Shares (ADXN)

Price$6.65

Value ScoreC

Growth ScoreF

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-36.62%

Price vs S&P 500 (4W)-12.60%

VGM Score27.14

Market Capitalization$6.94M

P/E Ratio (Annual)0.80x

All Metrics

Book Value / Share (Quarterly)$0.05

P/TBV (Annual)1.69x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-50.73%

Cash Flow / Share (Quarterly)$-0.02

Price vs S&P 500 (YTD)-26.97%

Net Profit Margin (TTM)-3892.09%

EPS (TTM)$-0.08

10-Day Avg Trading Volume0.22M

EPS Excl Extra (TTM)$-0.08

Revenue Growth (5Y)-46.32%

EPS (Annual)$-0.08

ROI (Annual)-140.13%

Gross Margin (Annual)-958.33%

Net Profit Margin (5Y Avg)-946.84%

Cash / Share (Quarterly)$0.02

Revenue Growth QoQ (YoY)-96.02%

P/E Normalized (Annual)0.80x

ROA (Last FY)-105.72%

Revenue Growth TTM (YoY)-78.57%

EBITD / Share (TTM)$-0.03

ROE (5Y Avg)-300.60%

Operating Margin (TTM)-1628.15%

Cash Flow / Share (Annual)$-0.02

P/B Ratio1.14x

P/B Ratio (Quarterly)1.69x

Net Income / Employee (Annual)$-4,303,200

EV / Revenue (TTM)22.10x

Net Interest Coverage (TTM)-0.70x

ROA (TTM)-84.94%

EPS Incl Extra (Annual)$-0.08

Current Ratio (Annual)1.40x

Quick Ratio (Quarterly)1.39x

3-Month Avg Trading Volume0.21M

52-Week Price Return-67.43%

Revenue / Employee (TTM)$110,519

Tangible BV / Share (Quarterly)$0.05

P/S Ratio (Annual)31.38x

Asset Turnover (Annual)0.03x

52-Week High$0.09

Operating Margin (5Y Avg)-869.64%

EPS Excl Extra (Annual)$-0.08

CapEx CAGR (5Y)-46.31%

Tangible BV CAGR (5Y)10.45%

26-Week Price Return-20.69%

Quick Ratio (Annual)1.39x

13-Week Price Return-4.17%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)1.40x

Enterprise Value$4.89M

Revenue / Share Growth (5Y)-59.42%

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-40.43%

Revenue / Employee (Annual)$110,519

Pretax Margin (Annual)-3958.46%

Cash / Share (Annual)$0.02

3-Month Return Std Dev89.35%

Gross Margin (5Y Avg)-178.93%

Net Income / Employee (TTM)$-4,303,200

ROE (Last FY)-141.15%

Net Interest Coverage (Annual)-0.70x

EPS Basic Excl Extra (Annual)$-0.08

Receivables Turnover (TTM)5.25x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.08

Receivables Turnover (Annual)20.05x

ROI (TTM)-102.01%

P/S Ratio (TTM)31.38x

Pretax Margin (5Y Avg)-1445.86%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.05

Price vs S&P 500 (52W)-66.60%

Year-to-Date Return-16.97%

5-Day Price Return-2.54%

EPS Normalized (Annual)$-0.08

ROA (5Y Avg)-117.13%

Net Profit Margin (Annual)-3892.31%

Month-to-Date Return-7.26%

Cash Flow / Share (TTM)$-0.27

EBITD / Share (Annual)$-0.03

Operating Margin (Annual)-1628.25%

LT Debt / Equity (Annual)1.77x

ROI (5Y Avg)-251.39%

LT Debt / Equity (Quarterly)0.53x

EPS Basic Excl Extra (TTM)$-0.08

P/TBV (Quarterly)1.69x

P/B Ratio (Annual)1.69x

Pretax Margin (TTM)-3958.22%

Book Value / Share (Annual)$0.05

Price vs S&P 500 (13W)-13.91%

Beta0.17x

P/FCF (Annual)3.11x

Revenue / Share (TTM)$0.00

ROE (TTM)-102.59%

52-Week Low$0.03

vGradeC

gGradeF

mGradeD

vgmGradeD

Show chart for

Analyst Recommendations

Oct 2025

Nov 2025

Dec 2025

Jan 2026

2.00

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ADXNAddex Therapeutics Ltd American Depositary Shares	C	F	D	$6.65
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company specializing in the development of allosteric modulators, an emerging class of orally available small-molecule drugs. Operating from its base in Switzerland and Europe, the company focuses on the discovery, development, and commercialization of these novel therapeutics.